Insider Selling: Cardinal Health (NYSE:CAH) CEO Sells $8,274,000.00 in Stock

Key Points

• Cardinal Health CEO Stephen Mason sold 35,000 shares at an average price of $236.40, generating $8.27 million and reducing his position by 65.96% to 18,061 shares.
• Cardinal Health reported quarterly EPS of $2.91, beating estimates of $2.42, while revenue rose 5.8% year over year to $63.67 billion but fell short of expectations.
• Analysts maintain a favorable outlook, with a consensus “Moderate Buy” rating and an average price target of $266.56; the company also declared a quarterly dividend of $0.5158 per share.

Cardinal Health, Inc. (NYSE:CAH - Get Free Report) CEO Stephen Mason sold 35,000 shares of Cardinal Health stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $236.40, for a total transaction of $8,274,000.00. Following the completion of the sale, the chief executive officer owned 18,061 shares in the company, valued at approximately $4,269,620.40. This trade represents a 65.96% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Cardinal Health Stock Performance

NYSE CAH opened at $234.73 on Thursday. Cardinal Health, Inc. has a one year low of $145.87 and a one year high of $258.30. The company has a market cap of $54.59 billion, a P/E ratio of 32.47, a P/E/G ratio of 1.26 and a beta of 0.49. The business has a fifty day moving average price of $231.76 and a 200 day moving average price of $217.68.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.42 by $0.49. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%.The business had revenue of $63.67 billion during the quarter, compared to the consensus estimate of $65.15 billion. During the same period last year, the company earned $2.08 EPS. The company's revenue for the quarter was up 5.8% on a year-over-year basis. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, sell-side analysts predict that Cardinal Health, Inc. will post 12.54 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be paid a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Thursday, October 1st. Cardinal Health's dividend payout ratio (DPR) is 28.49%.

Hedge Funds Weigh In On Cardinal Health

Several large investors have recently bought and sold shares of the stock. University of Texas Texas AM Investment Management Co. purchased a new stake in Cardinal Health in the fourth quarter valued at approximately $26,000. Bank of Jackson Hole Trust acquired a new stake in Cardinal Health during the 4th quarter worth $27,000. Jones Financial Companies Lllp grew its position in Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock worth $27,000 after purchasing an additional 14,034 shares during the last quarter. Palladiem LLC acquired a new position in Cardinal Health in the fourth quarter valued at $28,000. Finally, Indiana Trust & Investment Management Co purchased a new stake in shares of Cardinal Health in the first quarter valued at about $29,000. Institutional investors and hedge funds own 87.17% of the company's stock.

Analysts Set New Price Targets

CAH has been the topic of a number of research reports. UBS Group upped their price target on Cardinal Health from $274.00 to $280.00 and gave the stock a "buy" rating in a research note on Wednesday, August 12th. Weiss Ratings upgraded shares of Cardinal Health from a "buy (b)" rating to a "buy (b+)" rating in a report on Wednesday, August 5th. Barclays boosted their target price on Cardinal Health from $258.00 to $275.00 and gave the stock an "overweight" rating in a research note on Thursday, August 13th. Royal Bank Of Canada started coverage on Cardinal Health in a research report on Wednesday. They set an "outperform" rating and a $276.00 price objective for the company. Finally, Robert W. Baird lifted their price target on shares of Cardinal Health from $251.00 to $274.00 and gave the stock an "outperform" rating in a research note on Wednesday, August 12th. Sixteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $266.56.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source